Labeler
Actavis Pharma, Inc. NDC Codes
Actavis Pharma, Inc. lists 288 finished drug products in the FDA NDC Directory under NDC labeler codes 0228, 0472, 0591, 45963, 62037.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- methylphenidate hydrochloride, Testosterone, Isotretinoin, metoprolol succinate, Perphenazine, Lamotrigine, guanfacine, Potassium Citrate, Desvenlafaxine, memantine hydrochloride, Celecoxib, Mesalamine, Solifenacin succinate, Doxepin, Doxycycline Hyclate
- Active ingredients
- Methylphenidate hydrochloride, Testosterone, Isotretinoin, Metoprolol succinate, Perphenazine, Lamotrigine, Guanfacine hydrochloride, Potassium citrate, Desvenlafaxine succinate, Celecoxib, Mesalamine, Solifenacin succinate
- NDC labeler codes
- 0228, 0472, 0591, 45963, 62037
- Strengths (from the 100 most recently listed products)
- Testosterone 10 mg/g; Testosterone 16.2 mg/g; Naloxone hydrochloride 4 mg/.1mL; Mifepristone 300 mg/1; Dalfampridine 10 mg/1; Scopolamine 1 mg/3d; Bexarotene 75 mg/1; Isotretinoin 40 mg/1; Isotretinoin 25 mg/1; Isotretinoin 35 mg/1; Isotretinoin 10 mg/1; Isotretinoin 20 mg/1; Isotretinoin 30 mg/1; Mesalamine 1000 mg/1; Alvimopan 12 mg/1; Methylphenidate hydrochloride 60 mg/1; Methylphenidate hydrochloride 10 mg/1; Methylphenidate hydrochloride 15 mg/1; Methylphenidate hydrochloride 20 mg/1; Methylphenidate hydrochloride 30 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Film coated, Extended release, Tablet, Extended release, Capsule, Gel, Capsule, Extended release, Tablet, Tablet, Delayed release, Injection, Powder, Lyophilized, For solution, Cream, Tablet, For suspension, Solution, Injection, Solution, Spray, Metered, System, Capsule, Liquid filled, Suppository, Powder, For suspension, Suspension, Ointment, Aerosol, Metered, Powder, For solution, Kit
- Routes
- Oral, Topical, Intravenous, Transdermal, Sublingual, Nasal, Rectal
- Drug classes (FDA established)
- Central Nervous System Stimulant, Retinoid, Androgen, Anti-epileptic Agent, Nonsteroidal Anti-inflammatory Drug, Central alpha-2 Adrenergic Agonist, beta-Adrenergic Blocker, Endothelin Receptor Antagonist, Phenothiazine, Mood Stabilizer, Corticosteroid, Anti-coagulant, Calculi Dissolution Agent, Serotonin and Norepinephrine Reuptake Inhibitor, Opioid Antagonist, Aminosalicylate, Cholinergic Muscarinic Antagonist, Tricyclic Antidepressant, Tetracycline-class Drug, Iron Chelator, N-methyl-D-aspartate Receptor Antagonist, Topoisomerase Inhibitor, Partial Opioid Agonist, Progestin Antagonist, Potassium Channel Blocker, Anticholinergic, Phosphodiesterase 5 Inhibitor, Antiparasitic, Pediculicide, Substance P/Neurokinin-1 Receptor Antagonist, Melatonin Receptor Agonist, Antirheumatic Agent, Antihistamine, Vitamin B6 Analog, Anthelmintic, Calcineurin Inhibitor Immunosuppressant, Muscle Relaxant, beta2-Adrenergic Agonist, Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor, Nucleoside Analog Antiviral, Lincosamide Antibacterial, Monoamine Oxidase Inhibitor, Vinca Alkaloid, Aminoketone, Nucleoside Metabolic Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 121 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Naloxone Hydrochloride | Naloxone hydrochloride 4 mg/.1mL | Spray, MeteredNasal | 0591-3871 | 00591-3871-99 | — |
| Mifepristone | Mifepristone 300 mg/1 | Tablet, Film coatedOral | 0591-4390 | 00591-4390-96 | — |
| Dalfampridine | Dalfampridine 10 mg/1 | Tablet, Film coated, Extended releaseOral | 0591-2533 | 00591-2533-60 | — |
| scopolamine | Scopolamine 1 mg/3d | SystemTransdermal | 0591-2258 | 00591-2258-0400591-2258-2300591-2258-79 | — |
| bexarotene | Bexarotene 75 mg/1 | Capsule, Liquid filledOral | 0591-2832 | 00591-2832-01 | — |
| Isotretinoin | Isotretinoin 40 mg/1 | CapsuleOral | 0591-2436 | 00591-2436-15 | — |
| Isotretinoin | Isotretinoin 25 mg/1 | CapsuleOral | 0591-2451 | 00591-2451-15 | — |
| Isotretinoin | Isotretinoin 35 mg/1 | CapsuleOral | 0591-2501 | 00591-2501-15 | — |
| Isotretinoin | Isotretinoin 10 mg/1 | CapsuleOral | 0591-2433 | 00591-2433-15 | — |
| Isotretinoin | Isotretinoin 20 mg/1 | CapsuleOral | 0591-2434 | 00591-2434-15 | — |
| Isotretinoin | Isotretinoin 30 mg/1 | CapsuleOral | 0591-2435 | 00591-2435-15 | — |
| Mesalamine | Mesalamine 1000 mg/1 | SuppositoryRectal | 0472-1915 | 00472-1915-30 | — |
| Testosterone | Testosterone 16.2 mg/g | GelTransdermal | 0591-2926 | 00591-2926-30 | — |
| Alvimopan | Alvimopan 12 mg/1 | CapsuleOral | 0591-2312 | 00591-2312-15 | — |
| methylphenidate hydrochloride | Methylphenidate hydrochloride 60 mg/1 | Capsule, Extended releaseOral | 0591-3902 | 00591-3902-19 | — |
| methylphenidate hydrochloride | Methylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | 0591-3854 | 00591-3854-19 | — |
| methylphenidate hydrochloride | Methylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | 0591-3862 | 00591-3862-19 | — |
| methylphenidate hydrochloride | Methylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | 0591-3869 | 00591-3869-19 | — |
| methylphenidate hydrochloride | Methylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | 0591-3873 | 00591-3873-19 | — |
| methylphenidate hydrochloride | Methylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | 0591-3891 | 00591-3891-19 | — |
| methylphenidate hydrochloride | Methylphenidate hydrochloride 50 mg/1 | Capsule, Extended releaseOral | 0591-3895 | 00591-3895-19 | — |
| Sildenafil | Sildenafil citrate 10 mg/mL | Powder, For suspensionOral | 0591-4050 | 00591-4050-94 | — |
| Solifenacin succinate | Solifenacin succinate 5 mg/1 | Tablet, Film coatedOral | 0591-3795 | 00591-3795-1900591-3795-30 | — |
| Solifenacin succinate | Solifenacin succinate 10 mg/1 | Tablet, Film coatedOral | 0591-3796 | 00591-3796-1900591-3796-30 | — |
| metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Film coated, Extended releaseOral | 45963-676 | 45963-0676-1145963-0676-96 | — |
| Doxepin | Doxepin hydrochloride 3 mg/1 | Tablet, Film coatedOral | 0228-3315 | 00228-3315-03 | — |
| Doxepin | Doxepin hydrochloride 6 mg/1 | Tablet, Film coatedOral | 0228-3316 | 00228-3316-03 | — |
| metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Film coated, Extended releaseOral | 45963-677 | 45963-0677-1145963-0677-96 | — |
| metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Film coated, Extended releaseOral | 45963-678 | 45963-0678-11 | — |
| metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Film coated, Extended releaseOral | 45963-709 | 45963-0709-1145963-0709-96 | — |
| Ivermectin | Ivermectin 10 mg/g | CreamTopical | 0591-4052 | 00591-4052-89 | — |
| Fosaprepitant | Fosaprepitant dimeglumine 150 mg/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 0591-4385 | 00591-4385-79 | — |
| Doxycycline Hyclate | Doxycycline hyclate 50 mg/1 | Tablet, Delayed releaseOral | 0591-4550 | 00591-4550-22 | — |
| Doxycycline Hyclate | Doxycycline hyclate 200 mg/1 | Tablet, Delayed releaseOral | 0591-4575 | 00591-4575-60 | — |
| Ramelteon | Ramelteon 8 mg/1 | TabletOral | 0591-2191 | 00591-2191-0100591-2191-30 | — |
| Penicillamine | Penicillamine 250 mg/1 | CapsuleOral | 0591-4171 | 00591-4171-01 | — |
| Doxylamine succinate and pyridoxine hydrochloride | Doxylamine succinate 10 mg/1; Pyridoxine hydrochloride 10 mg/1 | Tablet, Delayed releaseOral | 0591-2132 | 00591-2132-01 | — |
| bosentan | Bosentan 62.5 mg/1 | Tablet, Film coatedOral | 0591-2511 | 00591-2511-60 | — |
| bosentan | Bosentan 125 mg/1 | Tablet, Film coatedOral | 0591-2512 | 00591-2512-60 | — |
| Albendazole | Albendazole 200 mg/1 | Tablet, Film coatedOral | 0591-2712 | 00591-2712-02 | — |
| Ambrisentan | Ambrisentan 5 mg/1 | Tablet, Film coatedOral | 0591-2405 | 00591-2405-30 | — |
| Ambrisentan | Ambrisentan 10 mg/1 | Tablet, Film coatedOral | 0591-2406 | 00591-2406-30 | — |
| Testosterone | Testosterone 16.2 mg/g | GelTransdermal | 0591-2924 | 00591-2924-18 | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | 45963-455 | 45963-0455-30 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | 45963-456 | 45963-0456-30 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 18 mg/1 | Tablet, Film coated, Extended releaseOral | 62037-725 | 62037-0725-01 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 36 mg/1 | Tablet, Film coated, Extended releaseOral | 62037-726 | 62037-0726-01 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 54 mg/1 | Tablet, Film coated, Extended releaseOral | 62037-727 | 62037-0727-01 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 27 mg/1 | Tablet, Film coated, Extended releaseOral | 62037-734 | 62037-0734-01 | — |
| Vigabatrin | Vigabatrin 500 mg/1 | Tablet, Film coatedOral | 0591-3851 | 00591-3851-01 | — |
Actavis Pharma, Inc.: common questions
- What is Actavis Pharma, Inc.'s NDC labeler code?
- 0228, 0472, 0591, 45963, 62037. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Actavis Pharma, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.